We find that TP53 loss phenocopies are remarkably common across tumors and cancer cell lines, and we identify USP28 gene deletions as one cause of TP53 loss phenocopying, and reveal many links between drugs and their targets that are modulated by TP53 activity. The gene discussed is USP28; the disease is cancer.